Darunavir Ethanolate/Cobicistat

乙醇达芦那韦/考比司他

Report date: 2026/03/13 20:02:36

Base Information

Drug NameDarunavir Ethanolate/Cobicistat
Drug Alias NameCobicistat/Darunavir EthanolateDarunavir/CobicistatDarunavir - cobicistat普泽力Rezolsta +[7] 
ClassificationSmall molecules
Mechanisms of ActionHuman immunodeficiency virus type 1 protease inhibitorsCytochrome P450 3A inhibitors
TargetsCytochrome P450 3AHuman immunodeficiency virus type 1 protease
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsHIV Infections
Approved Indications in ChinaHIV Infections
Original Approved Country/TerritoryEU
Original Approved Date2014/11/19
Country/TerritoryUnited StatesPuerto RicoSouth Africa +[8] 
CombinationsYes Darunavir EthanolateCobicistat
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesJohnson & Johnson Innovative Medicine
China Registration ClassN/A

Develop Information

Active CompaniesJanssen-Cilag International NvJanssen Products, LpJanssen Pharmaceutical Kk +[4] 
Inactive CompaniesJanssen-Cilag LtdJanssen Scientific Affairs Llc
Active IndicationsHIV Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ05AR14
Related LinksKEGG